1986
DOI: 10.1016/0002-9343(86)90807-7
|View full text |Cite
|
Sign up to set email alerts
|

Predicting outcome in coronary disease statistical models versus expert clinicians

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
44
1

Year Published

1986
1986
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 129 publications
(45 citation statements)
references
References 32 publications
0
44
1
Order By: Relevance
“…11,13,14,31,56,57 One possible reason for the more supportive results of this analysis is that physicians were allowed to label patients across a spectrum of risk, which is more consistent with the pathophysiology of disease. With the advent of observation units, rapid MI rule-out protocols, and CT coronary angiography, the array of ACS risk-stratification options has increased.…”
Section: Discussionmentioning
confidence: 99%
“…11,13,14,31,56,57 One possible reason for the more supportive results of this analysis is that physicians were allowed to label patients across a spectrum of risk, which is more consistent with the pathophysiology of disease. With the advent of observation units, rapid MI rule-out protocols, and CT coronary angiography, the array of ACS risk-stratification options has increased.…”
Section: Discussionmentioning
confidence: 99%
“…Initial evaluation, including a history and physical examination and 12-lead ECG, is conclusive in only a minority of patients. 1,2 The use of cardiac markers has become standard to further risk-stratify such patients. Often this is done in a chest pain unit (CPU), following protocols for marker testing over 6 to 12 hours.…”
mentioning
confidence: 99%
“…Table 1 demonstrates the survival times with medical and surgical therapy estimated from past experience with our patients at Duke. These estimated probabilities of survival at 1, 3, and 5 years are based on statistical models developed from our entire population of patients.17 18 The difference in survival with medical therapy is dramatic and the predicted benefit from surgery is quite different between the two patients. Because the randomized controlled trials have reported benefits only for the "average" patient, the clinician relying on this information alone is often ill-equipped to estimate the benefit of therapy for an individual patient.…”
mentioning
confidence: 99%